By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Vectura Group plc 

1 Prospect West

Chippenham  Wiltshire  SN14 6FH  United Kingdom
Phone: 44-0-1249-667700 Fax: 44-0-1249-667701


SEARCH JOBS


Industry
Pharmaceutical






Company News
Vectura Group plc (VEC.L)’s Investigational Drug/Device Combination VR475 Met Primary Endpoint And Has Shown Significant Clinical Benefit In A Phase 2b/3 Trial In Severe Asthma Patients 12/11/2014 6:35:04 AM
Vectura Group plc (VEC.L) Release: Approval In Ireland And Czech Republic For Innovative Respiratory Inhaler AirFluSal Forspiro 11/19/2014 9:31:33 AM
Vectura Group plc (VEC.L) Appoints Andrew Oakley As Group CFO 11/18/2014 4:17:10 PM
Vectura Group plc (VEC.L) VR315 U.S. Development Milestone 11/7/2014 9:10:52 AM
Vectura Group plc (VEC.L) Approval In Baltics For Innovative Respiratory Inhaler AirFluSal® Forspiro® 11/4/2014 10:10:20 AM
Vectura Group plc (VEC.L) Release: Approval In Portugal For Innovative Respiratory Inhaler AirFluSal® Forspiro® 10/9/2014 8:08:57 AM
Vectura Group plc (VEC.L) Release: Presentation At ERS 9/5/2014 9:03:54 AM
Vectura Group plc (VEC.L) Release: Announcement Of Commercial Arrangement With Pfizer Inc. (PFE) UK To Promote Ultibro® Breezhaler® And Seebri® Breezhaler® In The United Kingdom 9/4/2014 2:32:02 PM
Vectura Group plc (VEC.L) Release: Presentations At ERS 9/2/2014 9:47:24 AM
Vectura Group plc (VEC.L) First Approval In Latin America For Innovative Respiratory Inhaler AirFluSal#0174; Forspiro#0174; 8/21/2014 9:31:49 AM
12345678910
//-->